Blog
Taking Action for Health is Wealth
13 Oct 2022, noon in #insulin4all USA, Global Stories, News & Statements by T1International
T1International’s virtual #insulin4all Summit, Health is Wealth, was held on September 24th. Thank you everyone for your participation and read our recap here! Read more
The Long Road to US Federal Insulin Law and What More Needs to be Done
16 Sep 2022, noon in #insulin4all USA, News & Statements by T1International
The journey to move towards a federal insulin price cap has been long and difficult, including challenging incremental steps. The fight for a true insulin price cap in the US continues. Read more
5 Ways To Combat Pharma Talking Points with Just the Facts
12 Aug 2022, 6 a.m. in #insulin4all USA, Global Stories, News & Statements by T1International
Misinformation about diabetes and insulin is all too regularly spread in both the media and on social platforms. In this post, we outline 5 of the most common talking points used to explain away price gouging and how we can use the facts to overcome this narrative. Read more
Calling for Empowered Implementation of Global Diabetes Coverage Targets
11 Jul 2022, 9:59 p.m. in #insulin4all USA, Global Stories, News & Statements by T1International
At the 75th World Health Assembly (WHA) of the World Health Organization (WHO), member states adopted the first ever ‘Global Diabetes Coverage Targets,’ meant to steer the course of diabetes diagnosis and treatment for the next 8 years. Read more
The Realities of Diabetes Burnout
2 Jun 2022, 7:42 p.m. in News & Statements by Konstantina Taki
For too long, understanding the precise relationship between burnout and diabetes has been a mystery, and more data must be uncovered. Working with T1International, we are sharing a new survey on the impacts and implications of burnout for those with type 1 diabetes. Read more
T1International’s 2022 Out-of-Pocket Cost Survey: An Easy Way to Advocate
27 May 2022, 9:32 p.m. in #insulin4all USA, News & Statements by T1International
Take the Survey! The survey is for individuals over the age of 18 with type 1 diabetes. A parent or caregiver can take the survey for those under the age of 18. Caregivers can also take the survey for spouses or partners. The survey is anonymous and is completely optional. Read more
Global Advocacy Success Series: Lejla Druškić, Bosnia and Herzegovina
2 May 2022, 6:48 p.m. in Global Stories, Interviews, News & Statements by Katie Souris
Lejla Druškić, Global Advocate from Bosnia and Herzegovina, is a fearless speaker. Since joining T1International’s Global Advocacy Network in July 2021, she has been an invited speaker at the 3rd annual Congress of Diabetologists and Endocrinologists of Bosnia and Herzegovina, serving as a patient representative on a panel of patients and healthcare providers. Read more
Press Release: Human Rights Watch Calls Out Unaffordable Insulin as Human Rights Crisis
12 Apr 2022, 5:21 a.m. in #insulin4all USA, News & Statements by T1International
A report from Human Rights Watch powerfully illustrates the human impact of sky-high insulin prices through the testimony of 18 insulin-dependent people living with diabetes in the United States.
Read more
T1International Statement on HR 6833 and the Affordable Insulin Now Act Vote
31 Mar 2022, 8 p.m. in #insulin4all USA, News & Statements by T1International
On Thursday, March 31st, the US House of Representatives voted to pass a $35 insulin copay cap. The bill now heads to the Senate. While a $35 copay cap on insulin would impact many people, T1International is calling on the Senate to pass a true price cap on insulin for everyone, especially those without insurance. Read more
The Next 100 Years of Insulin
24 Mar 2022, 11:11 p.m. in #insulin4all USA, Global Stories, News & Statements by Ian Devaney
For some, the first 100 years of insulin has been a great, life-affirming success. For others, it has been a failure, where leaders and organizations in power have chosen profits over the lives and welfare of human beings. So how will we shape the next 100 years? Read more